TIBER CREEK GROUP for CIGNA CORPORATION AND SUBSIDIARIES
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Proposals impacting Medicare Advantage and Medicare Part D; Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy; H.R.5378 - Lower Cost, More Transparency Act. Issues related to pharmacy, prescription drugs, and health insurance in the Consolidated Appropriations Act, 2024, HR 4366.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW MCKECHNIE | — |
| TIMOTHY ROBINSON | — |
| JOHN KIRKLAND TWOMEY | — |
Health Issues HCR
Proposals impacting employer sponsored insurance, Medicare Advantage and Medicare Part D; Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy and prescription drug pricing policy; H.R.5378 - Lower Cost, More Transparency Act. Issues related to pharmacy, prescription drugs, and health insurance in the Consolidated Appropriations Act, 2024, HR 4366.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW MCKECHNIE | — |
| TIMOTHY ROBINSON | — |
| JOHN KIRKLAND TWOMEY | — |
Defense DEF
Pharmacy issues related to TRICARE; National Defense Authorization Act of Fiscal Year 2024 (PL 118-31).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREW MCKECHNIE | — |
| TIMOTHY ROBINSON | — |
| JOHN KIRKLAND TWOMEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.